Annual Current Liabilities
$37.08 M
-$16.65 M-30.99%
31 December 2023
Summary:
Allogene Therapeutics annual total current liabilities is currently $37.08 million, with the most recent change of -$16.65 million (-30.99%) on 31 December 2023. During the last 3 years, it has fallen by -$57.24 million (-60.69%). ALLO annual current liabilities is now -60.69% below its all-time high of $94.32 million, reached on 31 December 2020.ALLO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$32.57 M
-$4.73 M-12.69%
30 September 2024
Summary:
Allogene Therapeutics quarterly total current liabilities is currently $32.57 million, with the most recent change of -$4.73 million (-12.69%) on 30 September 2024. Over the past year, it has dropped by -$5.07 million (-13.46%). ALLO quarterly current liabilities is now -79.58% below its all-time high of $159.48 million, reached on 30 September 2018.ALLO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.0% | -13.5% |
| 3 y3 years | -60.7% | -39.1% |
| 5 y5 years | +25.9% | -2.4% |
ALLO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.7% | at low | -45.3% | +5.4% |
| 5 y | 5 years | -60.7% | +25.9% | -65.5% | +21.4% |
| alltime | all time | -60.7% | >+9999.0% | -79.6% | +120.9% |
Allogene Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.57 M(-12.7%) |
| June 2024 | - | $37.30 M(+20.8%) |
| Mar 2024 | - | $30.89 M(-16.7%) |
| Dec 2023 | $37.08 M(-31.0%) | $37.08 M(-1.5%) |
| Sept 2023 | - | $37.64 M(-31.2%) |
| June 2023 | - | $54.72 M(-8.2%) |
| Mar 2023 | - | $59.59 M(+10.9%) |
| Dec 2022 | $53.73 M(+12.2%) | $53.73 M(+9.9%) |
| Sept 2022 | - | $48.87 M(+8.8%) |
| June 2022 | - | $44.91 M(+21.8%) |
| Mar 2022 | - | $36.88 M(-23.0%) |
| Dec 2021 | $47.91 M | $47.91 M(-10.4%) |
| Sept 2021 | - | $53.49 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $46.00 M(-16.1%) |
| Mar 2021 | - | $54.85 M(-41.8%) |
| Dec 2020 | $94.32 M(+185.1%) | $94.32 M(+88.2%) |
| Sept 2020 | - | $50.13 M(+22.6%) |
| June 2020 | - | $40.90 M(+52.5%) |
| Mar 2020 | - | $26.82 M(-18.9%) |
| Dec 2019 | $33.08 M(+12.3%) | $33.08 M(-0.8%) |
| Sept 2019 | - | $33.35 M(-12.2%) |
| June 2019 | - | $38.00 M(+39.4%) |
| Mar 2019 | - | $27.27 M(-7.4%) |
| Dec 2018 | $29.46 M(>+9900.0%) | $29.46 M(-81.5%) |
| Sept 2018 | - | $159.48 M(+981.6%) |
| June 2018 | - | $14.74 M |
| Dec 2017 | $2000.00 | - |
FAQ
- What is Allogene Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Allogene Therapeutics?
- What is Allogene Therapeutics annual current liabilities year-on-year change?
- What is Allogene Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly current liabilities year-on-year change?
What is Allogene Therapeutics annual total current liabilities?
The current annual current liabilities of ALLO is $37.08 M
What is the all time high annual current liabilities for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total current liabilities is $94.32 M
What is Allogene Therapeutics annual current liabilities year-on-year change?
Over the past year, ALLO annual total current liabilities has changed by -$16.65 M (-30.99%)
What is Allogene Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ALLO is $32.57 M
What is the all time high quarterly current liabilities for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total current liabilities is $159.48 M
What is Allogene Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ALLO quarterly total current liabilities has changed by -$5.07 M (-13.46%)